The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Cannabis Effects on Driving Skills
Open accessAbstract
BACKGROUND: Cannabis is the most prevalent illicit drug identified in impaired drivers. The effects of cannabis on driving continue to be debated, making prosecution and legislation difficult. Historically, delays in sample collection, evaluating the inactive Δ9-tetrahydrocannabinol (THC) metabolite 11-nor-9-carboxy-THC, and polydrug use have complicated epidemiologic evaluations of driver impairment after cannabis use. CONTENT: We review and evaluate the current literature on cannabis' effects on driving, highlighting the epidemiologic and experimental data. Epidemiologic data show that the risk of involvement in a motor vehicle accident (MVA) increases approximately 2-fold after cannabis smoking. The adjusted risk of driver culpability also increases substantially, particularly with increased blood THC concentrations. Studies that have used urine as the biological matrix have not shown an association between cannabis and crash risk. Experimental data show that drivers attempt to compensate by driving more slowly after smoking cannabis, but control deteriorates with increasing task complexity. Cannabis smoking increases lane weaving and impaired cognitive function. Critical-tracking tests, reaction times, divided-attention tasks, and lane-position variability all show cannabis-induced impairment. Despite purported tolerance in frequent smokers, complex tasks still show impairment. Combining cannabis with alcohol enhances impairment, especially lane weaving. SUMMARY: Differences in study designs frequently account for inconsistencies in results between studies. Participant-selection bias and confounding factors attenuate ostensible cannabis effects, but the association with MVA often retains significance. Evidence suggests recent smoking and/or blood THC concentrations 2–5 ng/mL are associated with substantial driving impairment, particularly in occasional smokers. Future cannabis-and-driving research should emphasize challenging tasks, such as divided attention, and include occasional and chronic daily cannabis smokers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacokinetics and Pharmacodynamics of Cannabinoids
Grotenhermen, F. (2003) · Clinical Pharmacokinetics · doi:10.2165/00003088-200342040-00003 · Cited by 1,511
Asbridge, M., Hayden, J. A., & Cartwright, J. L. (2012) · BMJ · doi:10.1136/bmj.e536 · Cited by 735
Crean, R. D., Crane, N. A., & Mason, B. J. (2011) · Journal of Addiction Medicine · doi:10.1097/adm.0b013e31820c23fa · Cited by 732 · cited 1×
“Past experimental studies often were inconclusive because outcome measures lacked sensitivity and had not been tailored to specific THC effects (50, 51).”
BackgroundDose related risk of motor vehicle crashes after cannabis use
Ramaekers, J. G., Berghaus, G., van Laar, M., & Drummer, O. H. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2003.10.008 · Cited by 574
The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes
Drummer, O. H., Gerostamoulos, J., Batziris, H., Chu, M., Caplehorn, J., Robertson, M. D., & Swann, P. (2004) · Accident Analysis & Prevention · doi:10.1016/s0001-4575(02)00153-7 · Cited by 543
Huestis, M. A., Henningfield, J. E., & Cone, E. J. (1992) · Journal of Analytical Toxicology · doi:10.1093/jat/16.5.276 · Cited by 519
Self-citationHigh-Potency Marijuana Impairs Executive Function and Inhibitory Motor Control
Ramaekers, J. G., Kauert, G., van Ruitenbeek, P., Theunissen, E. L., Schneider, E., & Moeller, M. R. (2006) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301068 · Cited by 397
Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users
Ramaekers, J., Kauert, G., Theunissen, E., Toennes, S., & Moeller, M. (2009) · Journal of Psychopharmacology · doi:10.1177/0269881108092393 · Cited by 371
Effects of THC on Behavioral Measures of Impulsivity in Humans
McDonald, J., Schleifer, L., Richards, J. B., & de Wit, H. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300176 · Cited by 368
Marijuana Use and Motor Vehicle Crashes
Li, M.-C., Brady, J. E., DiMaggio, C. J., Lusardi, A. R., Tzong, K. Y., & Li, G. (2012) · Epidemiologic Reviews · doi:10.1093/epirev/mxr017 · Cited by 347
Cited by
Adverse health effects of marijuana use.
Volkow, N. D., Baler, R. D., Compton, W. M., & Weiss, S. R. B. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1402309 · Cited by 2,774
Prevalence of marijuana use disorders in the United States between 2001-2002 and 2012-2013.
Hasin, D. S., Saha, T. D., Kerridge, B. T., Goldstein, R. B., Chou, S. P., Zhang, H., Jung, J., Pickering, R. P., Ruan, W. J., Smith, S. M., et al. (2015) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.1858 · Cited by 1,086
The pharmacokinetics and the pharmacodynamics of cannabinoids
Lucas, C. J., Galettis, P., & Schneider, J. (2018) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13710 · Cited by 724
Acute and Chronic Effects of Cannabinoids on Human Cognition—A Systematic Review
Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.12.002 · Cited by 674
Hasin, D. S., Kerridge, B. T., Saha, T. D., Huang, B., Pickering, R., Smith, S. M., Jung, J., Zhang, H., & Grant, B. F. (2016) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2015.15070907 · Cited by 579
Hall, W. (2015) · Addiction · doi:10.1111/add.12703 · Cited by 579
US epidemiology of cannabis use and associated problems
Hasin, D. S. (2018) · Neuropsychopharmacology · doi:10.1038/npp.2017.198 · Cited by 578
“Cannabis use while driving has been shown to substantially increase the risk for motor vehicle crashes (Asbridge et al, 2012; Brady and Li, 2014; Li et al, 2012; National Academies of Sciences, 2017; Rogeberg and Elvik, 2016), and is implicated in fatal and nonfatal crashes (Asbridge et al, 2012; Brady and Li, 2014; H…”
BackgroundHill, K. P. (2015) · JAMA · doi:10.1001/jama.2015.6199 · Cited by 508
Azofeifa, A., Mattson, M. E., Schauer, G., McAfee, T., Grant, A., & Lyerla, R. (2016) · MMWR. Surveillance Summaries · doi:10.15585/mmwr.ss6511a1 · Cited by 461
Lower-Risk Cannabis Use Guidelines: A Comprehensive Update of Evidence and Recommendations
Fischer, B., Russell, C., Sabioni, P., van den Brink, W., Le Foll, B., Hall, W., Rehm, J., & Room, R. (2017) · American Journal of Public Health · doi:10.2105/ajph.2017.303818 · Cited by 433
Hasin, D. S., Sarvet, A. L., Cerdá, M., Keyes, K. M., Stohl, M., Galea, S., & Wall, M. M. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2017.0724 · Cited by 406
Traffic accidents involving fatigue driving and their extent of casualties
Zhang, G., Yau, K. K. W., Zhang, X., & Li, Y. (2016) · Accident Analysis & Prevention · doi:10.1016/j.aap.2015.10.033 · Cited by 350
Why young people's substance use matters for global health
Hall, W. D., Patton, G., Stockings, E., Weier, M., Lynskey, M., Morley, K. I., & Degenhardt, L. (2016) · The Lancet Psychiatry · doi:10.1016/s2215-0366(16)00013-4 · Cited by 334
Smart, R., & Pacula, R. L. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1669626 · Cited by 305
Hasin, D. S., Shmulewitz, D., & Sarvet, A. L. (2019) · The American Journal of Drug and Alcohol Abuse · doi:10.1080/00952990.2019.1569668 · Cited by 261
Page, R. L., Allen, L. A., Kloner, R. A., Carriker, C. R., Martel, C., Morris, A. A., Piano, M. R., Rana, J. S., Saucedo, J. F., & On behalf of the American Heart Association Clinical Pharmacology Committee and Heart Failure and Transplantation Committee of the Council on Clinical Cardiology; Council on Basic Cardiovascular Sciences; Council on Cardiovascular and Stroke Nursing; Council on Epidemiology and Prevention; Council on Lifestyle and Cardiometabolic Health; and Council on Quality of Care and Outcomes Research (2020) · Circulation · doi:10.1161/cir.0000000000000883 · Cited by 260
Positive and Negative Effects of Cannabis and Cannabinoids on Health
Cohen, K., Weizman, A., & Weinstein, A. (2019) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.1381 · Cited by 255
McCartney, D., Arkell, T. R., Irwin, C., & McGregor, I. S. (2021) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2021.01.003 · Cited by 170
Onaemo, V. N., Fawehinmi, T. O., & D'Arcy, C. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.12.043 · Cited by 152
Farrelly, K. N., Wardell, J. D., Marsden, E., Scarfe, M. L., Najdzionek, P., Turna, J., & MacKillop, J. (2023) · Substance Abuse Research and Treatment · doi:10.1177/11782218231172054 · Cited by 162
Adolescents are more sensitive than adults to acute behavioral and cognitive effects of THC
Murray, C. H., Huang, Z., Lee, R., & de Wit, H. (2022) · Neuropsychopharmacology · doi:10.1038/s41386-022-01281-w · Cited by 46
Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)
Rock, K. L., Englund, A., Morley, S., Rice, K., & Copeland, C. S. (2022) · Journal of Psychopharmacology · doi:10.1177/02698811221115760 · Cited by 32
Psychotic disorder and cannabis use: Canadian hospitalization trends, 2006–2015
Maloney-Hall, B., Wallingford, S. C., Konefal, S., & Young, M. M. (2020) · Health Promotion and Chronic Disease Prevention in Canada · doi:10.24095/hpcdp.40.5/6.06 · Cited by 21
Metadata
- Authors
- Hartman, R. L., & Huestis, M. A.
- Venue
- Clinical Chemistry
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-03-01
- Volume
- 59
- Issue
- 3
- Pages
- 478-492
- ISSN
- 0009-9147 (ISSN-L)
- 1530-8561
- OpenAlex
- W2023544874
- Cited by
- 617
- References
- 57
- FWCI
- 64.81
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.